Thalidomide for the treatment of leptomeningeal multiple myeloma

被引：21
|
作者：
Hattori, Y
Yabe, M
Okamoto, S
Morita, K
Tanigawara, Y
Ikeda, Y
机构：
[1] Keio Univ, Sch Med, Div Hematol, Dept Med,Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Sch Med, Dept Hosp Pharm, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF HAEMATOLOGY | 2006年 / 76卷 / 04期
关键词：
D O I：
10.1111/j.1600-0609.2005.00591.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：358 / 359
页数：2
相关论文
共 50 条
  • [41] Pathophysiological considerations to thrombophilia in the treatment of multiple myeloma with thalidomide and derivates
    Gieseler, Frank
    THROMBOSIS AND HAEMOSTASIS, 2008, 99 (06) : 1001 - 1007
  • [42] Reversible Pulmonary Hypertension Related to Thalidomide Treatment for Multiple Myeloma
    Villa, Antonio
    Mazzola, Anna Alice
    Ghio, Stefano
    Martinoli, Elena
    Marino, Pietro
    CASE REPORTS IN ONCOLOGY, 2011, 4 (03): : 487 - 489
  • [43] Oral melphalan, dexamethasone, and thalidomide for the treatment of refractory multiple myeloma
    Asoua, Norio
    Izuno, Yoshiharu
    Okubo, Toshiya
    Ide, Kazuhiko
    Ueno, Hiroshi
    Kawakita, Makoto
    Hiroaki, Mitsuya
    Hata, Hiroyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 86 (01) : 69 - 71
  • [44] Oral Melphalan, Dexamethasone, and Thalidomide for the Treatment of Refractory Multiple Myeloma
    Norio Asou
    Yoshiharu Izuno
    Toshiya Okubo
    Kazuhiko Ide
    Hiroshi Ueno
    Makoto Kawakita
    Hiroaki Mitsuya
    Hiroyuki Hata
    International Journal of Hematology, 2007, 86 : 69 - 71
  • [45] Treatment of multiple myeloma with immunomodulatory drugs - thalidomide, lenalidomide and pomalidomide
    Rzepecki, Piotr
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2009, 13 (05): : 265 - 275
  • [46] Thalidomide and dexamethasone in the treatment of multiple myeloma:: progressing step by step
    Gonzalez Gonzalez, Bernardo J.
    Hernandez Nieto, Luis
    MEDICINA CLINICA, 2007, 128 (04): : 133 - 134
  • [47] Isolated Leptomeningeal Recurrence of Multiple Myeloma
    Sharma, Amit K.
    Joseph, Mariamma
    Climans, Seth A.
    NEUROHOSPITALIST, 2021, 11 (01): : 87 - 88
  • [48] Thalidomide-induced severe neutropenia during treatment of multiple myeloma
    Yutaka Hattori
    Tsunayuki Kakimoto
    Shinichiro Okamoto
    Norihide Sato
    Yasuo Ikeda
    International Journal of Hematology, 2004, 79 : 283 - 288
  • [49] Toxic epidermal necrolysis induced by thalidomide and dexamethasone treatment for multiple myeloma
    Hwang, Sewon
    Woo, Yuri
    Kim, Miri
    Park, Hyun Jeong
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2017, 56 (02) : e35 - e37
  • [50] INDICATION OF THALIDOMIDE DRUG FOR THE TREATMENT OF MULTIPLE MYELOMA: AN EVALUATION FOR RENAME UPDATE
    Pereira, M. C.
    Pitta, M. G.
    Rego, M. J.
    Oliveira, P. S.
    Zanghelini, F.
    Leite, B.
    Andrade, C. A.
    Andrade, M. D.
    VALUE IN HEALTH, 2015, 18 (07) : A817 - A817
12345